Jaguar Health Inc reports results for the quarter ended in September - Earnings Summary

Jaguar Health

14/11/2022 14:32

* Jaguar Health Inc  JAGX.OQ  reported a quarterly adjusted
loss
of 12 cents​​ per share for the quarter ended in September. The
mean expectation of two analysts for the quarter was for a loss
of 7 cents per share.
    * Revenue rose 400% to $3.15 million from a year ago;
analysts
expected $3.55 million. 
    * Jaguar Health Inc's reported EPS for the quarter was a
loss
of 12 cents​.
    * The mean earnings estimate of analysts had risen by
about 67.4%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Jaguar Health Inc shares had fallen by 3.8% this
quarter and
lost 85.6% so far this year.
    * The company reported a quarterly loss of $12.52 million.
    * Wall Street's median 12-month price target for Jaguar
Health Inc
is $4.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
14 at 02:31 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.07          -0.12          Missed
 Jun. 30 2022      -0.22          -0.12          Beat
 Mar. 31 2022      -0.17          -0.40          Missed
 Dec. 31 2021      -0.09          -0.31          Missed